Health
Argonne’s Advanced Photon Source guided the development of new COVID-19 vaccine now in trials – News-Medical.net
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two…
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two of the variants emerging around the world. The development of this new vaccine was guided by structural information on the virus obtained at the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory, and other light sources.
Trials are taking place at the Walter…
-
Noosa News11 hours agoSunshine Coast shines in tourism awards
-
Noosa News21 hours agoCorey Rocchiccioli stars as WA beats Queensland in one-wicket Sheffield Shield thriller
-
General22 hours agoMore than 11,000 homes lose power as storms with spectacular lightning hit south-east Queensland
-
Noosa News24 hours agoRight-wing group founder added to Qld school curriculum board
